Roundtable: Scaling Patient Engagement Measurement in Biotech Without Big- Pharma Resources

• Prioritizing high-value metrics that matter to leadership, partners, and regulators
• Embedding lightweight tracking into existing workflows to avoid measurement fatigue
• Leveraging outsourced partners, CROs, and patient groups to extend capacity
• Preparing early-stage measurement foundations that scale as the organization grows
• Tracking the long-term benefits of patient engagement to demonstrate value to the organization over time

Speakers:

Elsa LaVita

Senior Director, Patient Advocacy

Cullinan Therapeutics